CD4 and infection: Of the remaining 5 vaccinees, 3 (AG291, AH776, M770F) did not experience any loss of CD4+ T cell during the acute, post-acute and chronic phase of infection, maintaining CD4+ T cell counts comparable to the baseline values (range 1,104−2,309 cells/mmc).